Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/4/2025

EVD Placement in Patients with Severe Brain Injury and DNR Status

Indications and Contraindications for EVD Placement

  • The American Heart Association guidelines recommend EVD for patients with GCS >3 and hydrocephalus causing decreased consciousness, but a GCS of 5 falls into a gray zone where survival is possible but functional recovery is highly unlikely 1
  • EVD is contraindicated in patients with GCS ≤3 and has extremely limited benefit in GCS 4-5, with evidence supporting this exclusion due to universally poor prognosis regardless of intervention 1

Outcomes and Benefits of EVD Placement

  • While EVD placement reduces mortality in ICH/IVH with hydrocephalus, the benefit for improving functional outcomes is not well established, making it a critical distinction when considering goals of care in a DNR patient 2, 3, 1
  • EVD placement is an invasive procedure with significant complications, including infection rates of 27.6%, hemorrhagic complications, and the need for ICU-level care with potential progression to permanent shunt dependency in 8.9-48% of survivors 4

Considerations for Patients with Metastatic Cancer and DNR Status

  • The presence of metastatic cancer fundamentally alters the treatment goals, with a DNR order typically reflecting discussions about limiting aggressive interventions that prolong dying rather than restore meaningful function 1
  • A DNR order addresses resuscitation in the event of cardiopulmonary arrest, not all medical interventions, but often signals broader goals-of-care discussions about the intensity of interventions 4

Guidelines for EVD Placement in Specific Clinical Scenarios

  • For aneurysmal SAH with hydrocephalus, EVD is a Class 1 indication when it causes decreased consciousness, as it reduces mortality 5, 4, 1